FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

24618011000001100: Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Jun 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
80042901000001111 Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80043001000001119 Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Has specific active ingredient Recombinant human bone morphogenetic protein 7 true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Is a Eptotermin alfa 3.3mg powder for implantation suspension vials true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Has specific active ingredient Eptotermin alfa false Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Has dispensed dose form Implantation suspension true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Is a Osigraft true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Has active ingredient Recombinant human bone morphogenetic protein 7 true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Has manufactured dose form Implantation suspension false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Has AMP True Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start